Literature DB >> 26940041

Cancer Communication in the Social Media Age.

Mina S Sedrak1, Roger B Cohen1, Raina M Merchant2, Marilyn M Schapira3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26940041     DOI： 10.1001/jamaoncol.2015.5475

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  25 in total

1.  Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Jean-Jacques Kiladjian; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 2.  Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Authors:  Naveen Pemmaraju; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

3.  Beyond the Drama: the Beautiful Life in News Feeds on Cancer.

Authors:  Luisa Picanço; Priscila Biancovilli; Claudia Jurberg
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

4.  Clinical Trials in the Era of Digital Engagement: A SWOG Call to Action.

Authors:  Krishna S Gunturu; Don S Dizon; Judy Johnson; Anne Marie Mercurio; Ginny Mason; Dana B Sparks; Wendy Lawton; Jennifer R Klemp
Journal:  JCO Clin Cancer Inform       Date:  2020-03

Review 5.  Twitter Use in the Hematopoietic Cell Transplantation Community.

Authors:  Sagar S Patel; Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

6.  Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.

Authors:  Don S Dizon; Mina S Sedrak; Mark A Lewis; Elise Cook; Michael J Fisch; Jennifer R Klemp; Jonathan Sommers; AnneMarie Ciccarella; Julie Gralow; Wendy Lawton; Craig Nichols
Journal:  JCO Clin Cancer Inform       Date:  2018-12

7.  Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.

Authors:  Naveen Pemmaraju; Michael A Thompson; Ruben A Mesa; Tejas Desai
Journal:  J Oncol Pract       Date:  2017-05-17       Impact factor: 3.840

Review 8.  Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine.

Authors:  Deanna J Attai; Patricia F Anderson; Michael J Fisch; David L Graham; Matthew S Katz; Jennifer Kesselheim; Merry Jennifer Markham; Nathan A Pennell; Mina S Sedrak; Michael A Thompson; Audun Utengen; Don S Dizon
Journal:  Semin Hematol       Date:  2017-08-12       Impact factor: 3.851

Review 9.  The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette.

Authors:  Naveen Pemmaraju; Ruben A Mesa; Navneet S Majhail; Michael A Thompson
Journal:  Semin Hematol       Date:  2017-08-24       Impact factor: 3.851

Review 10.  Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Jean-Jacques Kiladjian; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.